TR201718258A2 - Tamoksifen dirençli meme kanseri tedavisi için geliştirilen yeni stratejiler. - Google Patents

Tamoksifen dirençli meme kanseri tedavisi için geliştirilen yeni stratejiler. Download PDF

Info

Publication number
TR201718258A2
TR201718258A2 TR2017/18258A TR201718258A TR201718258A2 TR 201718258 A2 TR201718258 A2 TR 201718258A2 TR 2017/18258 A TR2017/18258 A TR 2017/18258A TR 201718258 A TR201718258 A TR 201718258A TR 201718258 A2 TR201718258 A2 TR 201718258A2
Authority
TR
Turkey
Prior art keywords
treatment
breast cancer
new strategies
resistant breast
tamoxifen resistant
Prior art date
Application number
TR2017/18258A
Other languages
English (en)
Inventor
Şahi̇n Özgür
R Mishra Rasmi
Original Assignee
Ihsan Dogramaci Bilkent Ueniversitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ihsan Dogramaci Bilkent Ueniversitesi filed Critical Ihsan Dogramaci Bilkent Ueniversitesi
Priority to TR2017/18258A priority Critical patent/TR201718258A2/tr
Publication of TR201718258A2 publication Critical patent/TR201718258A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Buluş, meme kanseri tedavisinde ve özellikle tamoksifen direnci geliştiren hastalarda kullanılabilecek, siklik adenozin monofosfatın (cAMP) indüklenmesini sağlayan fosfodiesteraz 4D (PDE4D) modülatörleriyle ilgilidir.
TR2017/18258A 2017-11-17 2017-11-17 Tamoksifen dirençli meme kanseri tedavisi için geliştirilen yeni stratejiler. TR201718258A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/18258A TR201718258A2 (tr) 2017-11-17 2017-11-17 Tamoksifen dirençli meme kanseri tedavisi için geliştirilen yeni stratejiler.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/18258A TR201718258A2 (tr) 2017-11-17 2017-11-17 Tamoksifen dirençli meme kanseri tedavisi için geliştirilen yeni stratejiler.

Publications (1)

Publication Number Publication Date
TR201718258A2 true TR201718258A2 (tr) 2019-06-21

Family

ID=67952405

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/18258A TR201718258A2 (tr) 2017-11-17 2017-11-17 Tamoksifen dirençli meme kanseri tedavisi için geliştirilen yeni stratejiler.

Country Status (1)

Country Link
TR (1) TR201718258A2 (tr)

Similar Documents

Publication Publication Date Title
JOP20200192A1 (ar) أجسام مضادة لـ tigit
DOP2017000025A (es) Composiciones y métodos de uso para tratar trastornos metabólicos
SA521422089B1 (ar) c أجسام مضادة مكتسبة للسمة البشرية ضد مجموعة
CL2017000864A1 (es) Composiciones y métodos de uso para tratar trastornos metabólicos
EA201792642A1 (ru) Способы диагностики для т-клеточной терапии
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
BR112016026950A2 (pt) composições de rnai para angiotensinogênio (agt) e métodos de uso das mesmas
EA201691607A1 (ru) Микроорганоиды и способы их получения и применения
EA201790273A1 (ru) Флагеллиновые композиции и их применение
PH12015502788A1 (en) Antibody formulations and methods
JOP20190055A1 (ar) أجسام مضادة ضد cd27
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
CL2017002781A1 (es) Métodos de tratamiento de enfermedad de alzheimer
MX2017011194A (es) Anticuerpos, usos y métodos.
SV2018005730A (es) Biomarcadores para copanlisib
NZ763377A (en) Dantrolene prodrugs and methods of their use
CL2015003563A1 (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos.
MX392976B (es) Composiciones que comprenden cepas bacterianas.
TWD190452S (zh) 口腔保健器具
BR112017025553A2 (pt) composição de vacina, e kit
MX377276B (es) Profármacos de antagonista de (s)-1-fenil-2-(piridin-2-il) etanamina (nmda).
BR112016020043A2 (pt) composições e métodos para a identificação de malignidades de linfócitos b responsivas à terapia de depleção de linfócitos b
EA201690709A1 (ru) Применение одипарцила в лечении мукополисахаридоза
PL408305A1 (pl) Zastosowanie ceramidu C16 (C16-Cer) jako biomarkera w predykcji porodu przedwczesnego
EA202092495A1 (ru) МОДУЛЯТОРЫ Cot И СПОСОБЫ ИХ ПРИМЕНЕНИЯ